Selectis Health (GBCS) Common Equity (2011 - 2025)

Selectis Health has disclosed Common Equity across 15 years of filings, most recently posting -$6.2 million for Q4 2025.

• Common Equity for Q4 2025 came in at -$6.2 million, down 14.79% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.2 million (down 14.79% YoY), and the FY2025 annual result was -$6.2 million, down 14.79% from the prior year.
• Common Equity came in at -$6.2 million for Q4 2025 at Selectis Health, down from -$5.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $5.0 million in Q1 2023 to a low of -$6.4 million in Q2 2025.
• The 5-year median for Common Equity is $814799.0 (2022), against an average of -$591118.8.
• Across the five-year window, Common Equity surged 684.92% in 2021 and plunged 814.25% in 2024, its largest moves.
• Selectis Health's Common Equity stood at $3.1 million in 2021, then sank by 69.29% to $952835.0 in 2022, then plunged by 411.05% to -$3.0 million in 2023, then sank by 82.54% to -$5.4 million in 2024, then dropped by 14.79% to -$6.2 million in 2025.
• The last three Common Equity figures came in at -$6.2 million (Q4 2025), -$5.7 million (Q3 2025), and -$6.4 million (Q2 2025), per Business Quant data.